The FDA will continue recommending annual COVID-19 vaccines for older adults and high-risk groups, but says more clinical data is needed for healthy adults and kids.

On May 20, U.S. Food and Drug Administration (FDA) officials announced that Covid-19 vaccines will no longer be available to ...

U.S. Social Security Administration Commissioner Frank Bisignano discusses the potential opportunities for fraud in the program, an incentive in the 'big, beautiful bill' for recipients and efforts to ...

Its new guidance would trade the clarity and reach of our current strategy for a confusing framework that simply doesn’t fit reality.

The best approach to covid-19 prevention may be to discuss it with your doctor, a leading vaccine expert told TribLive. But a drastic shift in national policy published Tuesday in the New England ...

Photo: Adobe Stock The Food and Drug Administration (FDA) published new Evidence-Based guidelines for COVID-19 vaccination ...

US Food and Drug Administration officials are changing the agency's standards for updated COVID-19 booster shots with focus ...

FDA changes COVID-19 vaccine approval policy, major trials now required for widespread use. Higher risk individuals still ...

For groups younger than 65 or without specific chronic conditions, postmarketing trials will be needed to open access.

The FDA is getting rid of the Covid booster because . . . it's concerned about anti-vaxx sentiments. No, really.

In this week’s edition of InnovationRx, we look at the FDA's new rules on Covid-19 vaccines, Novartis’s acquisition strategy, ...

FDA leaders say the agency will require more clinical trials to show the benefits of annual COVID shots for healthy adults.